Regulation of central tolerance and Treg development by recirculating Treg
Regulation of central tolerance and Treg development by recirculating Treg
批准号:
10363236
负责人:
Michael Archibald Farrar
金额:
$38.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-05-01 至 2027-04-30
关键词:
AdultAffectAgeAntigen-Presenting CellsAntigensAutoimmunityBackBiologicalCell CountCell DensityCellsCellular Indexing of Transcriptomes and Epitopes by SequencingClonal DeletionCytolysisDevelopmentDiseaseEffector CellEnsureEquilibriumFOXP3 geneGrowthHeterogeneityHomeostasisHumanImmuneImmune ToleranceImmune responseImmune systemImmunityImmunologic SurveillanceImpairmentInfectionLifeMaintenanceMediatingMusOutputPerinatalPeripheralPlayPopulationProcessRegulationRegulatory T-LymphocyteRoleSelf ToleranceSiteSystemT cell receptor repertoire sequencingT-Cell DevelopmentT-cell diversityT-cell receptor repertoireTNFSF10 geneTNFSF6 geneTestingThymic epithelial cellThymus GlandTimeautoreactive T cellautoreactivitybasecentral tolerancecross reactivityeffector T cellexperimental studyimmunopathologymouse modelnovelpathogenperforinpreventthymocytetranscription factortranscriptome sequencingtranscriptomicstumoryoung adult
中文摘要
项目总结
有效的细胞免疫依赖于两个主要系统:(1)产生不同TCR的能力
能够识别来自以前未见过的病原体的抗原的谱系,以及(Ii)能够
区分自身和非自身抗原,防止自身免疫。不适当的平衡
这两个系统导致多种疾病状态,包括无效的肿瘤免疫监测和糟糕的
由于TCR谱系中的空白或自身免疫和脱靶而导致的病原体清除
感染过程中的免疫病理学。自身免疫可以通过删除自身反应性TCR或转移
它们进入胸腺中的Treg血统。然而,鉴于TCR的高度交叉反应,这
过程不能真正有效地去除所有自反应TCR,因为这将去除大部分潜在的
传统TCR曲目的多样性,从而削弱了对病原体的免疫力。因此,一个关键的生物
问题是胸腺的选择是如何平衡保护和自身免疫的,同时提供
对病原体的有效免疫力。我们假设有一组独特的胸腺循环
Treg细胞(RT-Treg)充当变阻器,以降低外周Treg细胞选择的严谨性
建立了耐受性,从而允许更多样化和病原体反应性的常规
免疫系统。这将在两个具体目标中进行检查:目标1:定义RT-Treg异质性和
RT-Treg累积的功能后果。目的2:确定RT-Treg细胞影响的机制
免疫谱系和mTEC编号。拟议的实验将阐明RT-Treg在
管理中枢耐受的严格性,既促进效应细胞多样性,又确保维持
特雷格细胞的自我耐受性。
英文摘要
PROJECT SUMMARY
Effective cell-based immunity depends on two major systems: (i) the ability to generate a diverse TCR
repertoire capable of recognizing antigens from previously unencountered pathogens, and (ii) the ability to
discriminate between self- and non-self-antigens and prevent autoimmunity. Inappropriate balance between
these two systems causes a variety of disease states including ineffective tumor immune surveillance and poor
pathogen clearance due to gaps in the TCR repertoire, or the onset of autoimmunity and off target
immunopathology during infection. Autoimmunity can be curtailed by deleting autoreactive TCRs or diverting
them into the Treg lineage in the thymus. However, given the high degree of cross-reactivity of TCRs this
process cannot be truly efficient at removing all self-reactive TCRs as this would remove much of the potential
diversity of the conventional TCR repertoire, thereby impairing immunity to pathogens. Thus, a key biological
question is how thymic selection functions to balance protection against autoimmunity while providing
effective immunity against pathogens. We hypothesize that a unique population of thymic recirculating
Treg cells (RT-Treg) act as a rheostat to decrease the stringency of selection once peripheral Treg cell
tolerance is established, thereby allowing for a more diverse and pathogen-reactive conventional
immune system. This will be examined in two specific aims: Aim 1: Define RT-Treg heterogeneity and
functional consequences of RT-Treg accumulation. Aim 2: Identify the mechanisms by which RT-Treg cells affect
immune repertoires and mTEC numbers. The proposed experiments will elucidate the role that RT-Treg play in
governing the stringency of central tolerance, both promoting effector cell diversity and ensuring maintenance
of self-tolerance by Treg cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulatory T Cells in Alzheimer's Disease
-
批准号:10515396
-
项目类别:
-
资助金额:$76.88万
-
财政年份:2022
-
负责人:Michael Archibald Farrar
-
依托单位:
Regulation of central tolerance and Treg development by recirculating Treg
-
批准号:10615598
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2022
-
负责人:Michael Archibald Farrar
-
依托单位:
Regulatory T Cells in Alzheimer's Disease
-
批准号:10685434
-
项目类别:
-
资助金额:$76.88万
-
财政年份:2022
-
负责人:Michael Archibald Farrar
-
依托单位:
Co-repressors in STAT5-dependent CD4+ T Cell Development and Function
-
批准号:10614429
-
项目类别:
-
资助金额:$48.48万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:10059179
-
项目类别:
-
资助金额:$37.67万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:10319979
-
项目类别:
-
资助金额:$36.91万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:10550155
-
项目类别:
-
资助金额:$36.91万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Co-repressors in STAT5-dependent CD4+ T Cell Development and Function
-
批准号:10382260
-
项目类别:
-
资助金额:$48.48万
-
财政年份:2019
-
负责人:Michael Archibald Farrar
-
依托单位:
Development of Immune Tolerance
-
批准号:10338131
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2016
-
负责人:Michael Archibald Farrar
-
依托单位:
Development of Immune Tolerance
-
批准号:10573296
-
项目类别:
-
资助金额:$45.37万
-
财政年份:2016
-
负责人:Michael Archibald Farrar
-
依托单位:
TNF Receptor Superfamily Signaling in Immune Tolerance
-
批准号:8894185
-
项目类别:
-
资助金额:$37.64万
-
财政年份:2014
-
负责人:Michael Archibald Farrar
-
依托单位:
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
-
批准号:9063487
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2014
-
负责人:Michael Archibald Farrar
-
依托单位:
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
-
批准号:9262063
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2014
-
负责人:Michael Archibald Farrar
-
依托单位:
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
-
批准号:8686567
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2014
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:8230503
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
-
批准号:8307275
-
项目类别:
-
资助金额:$30.72万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:8617815
-
项目类别:
-
资助金额:$30.11万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
-
批准号:8843379
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
-
批准号:8105994
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
-
批准号:8677789
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2011
-
负责人:Michael Archibald Farrar
-
依托单位:
海外基金